• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

压力脉冲皮质类固醇吸入治疗慢性鼻-鼻窦炎

Treatment of chronic rhinosinusitis with pressure-pulsed corticosteroid inhalation.

作者信息

Goektas Oender, Lau Larissa, Olze Heidi

机构信息

Department of Otolaryngology-Head and Neck Surgery, University of Berlin, Charité Campus Mitte, Smell and Taste Consultation Service, Berlin, Germany.

出版信息

Indian J Otolaryngol Head Neck Surg. 2013 Aug;65(Suppl 2):402-5. doi: 10.1007/s12070-013-0625-y. Epub 2013 Feb 15.

DOI:10.1007/s12070-013-0625-y
PMID:24427686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3738806/
Abstract

Chronic rhinosinusitis may cause olfactory dysfunction and affects quality of life in patients. In a prospective study we investigated the effect of topical application of corticosteroids through pressure-pulsed inhalation as treatment option of chronic rhinosinusitis with olfactory disorder. Patients with sinonasal olfactory disorder according to the European Position Paper on Rhinosinusitis and Nasal Polyps (EP3OS) were allocated to the new nasal inhalation therapy or a systemic corticosteroid therapy, each receiving a corticosteroid course of 12 days. 18 patients received topical corticosteroid pressure-pulsed inhalation (AMSA, Schumacher, Dausenau) and 15 systemic corticosteroid. Olfactory function was measured before and after treatment using the Threshold Discrimination Identification score (TDI score) and visual analogue scales. Lund Mackay score (LMS) was measured before starting treatment. Olfactory function (OF) increased from 17.5 ± 6.4 to 21 ± 7.9 TDI points (p < 0.0005) after 2 months. OF decreased again to 19.5 ± 6.0 after 6 months (p = 0.007). OF increased from 17.0 ± 8.9 to 22.0 ± 9.5 points (p = 0.002) with systemic treatment after 2 months. In the follow-up period of 6 months, the mean TDI score dropped to 20.0 ± 9.2 points (p = 0.01). There was no correlation between LMS and TDI. Treatment of chronic rhinosinusitis with pressure-pulsed inhalation was demonstrated to be effective. Multicenter investigations with large participant numbers are needed.

摘要

慢性鼻窦炎可能导致嗅觉功能障碍,并影响患者的生活质量。在一项前瞻性研究中,我们调查了通过压力脉冲吸入局部应用皮质类固醇作为慢性鼻窦炎伴嗅觉障碍治疗方案的效果。根据欧洲鼻窦炎和鼻息肉立场文件(EP3OS)诊断为鼻窦嗅觉障碍的患者被分配接受新的鼻腔吸入疗法或全身皮质类固醇疗法,每种疗法均接受为期12天的皮质类固醇疗程。18例患者接受局部皮质类固醇压力脉冲吸入(AMSA、舒马赫、道塞纳),15例接受全身皮质类固醇治疗。治疗前后使用阈值辨别识别评分(TDI评分)和视觉模拟量表测量嗅觉功能。在开始治疗前测量Lund Mackay评分(LMS)。2个月后,嗅觉功能(OF)从17.5±6.4 TDI点增加到21±7.9 TDI点(p<0.0005)。6个月后,OF再次降至19.5±6.0(p=0.007)。全身治疗2个月后,OF从17.0±8.9分增加到22.0±9.5分(p=0.002)。在6个月的随访期内,平均TDI评分降至20.0±9.2分(p=0.01)。LMS与TDI之间无相关性。压力脉冲吸入治疗慢性鼻窦炎被证明是有效的。需要进行有大量参与者的多中心研究。

相似文献

1
Treatment of chronic rhinosinusitis with pressure-pulsed corticosteroid inhalation.压力脉冲皮质类固醇吸入治疗慢性鼻-鼻窦炎
Indian J Otolaryngol Head Neck Surg. 2013 Aug;65(Suppl 2):402-5. doi: 10.1007/s12070-013-0625-y. Epub 2013 Feb 15.
2
Olfactory cleft and sinus opacification differentially impact olfaction in chronic rhinosinusitis.嗅裂及窦口鼻道复合体阻塞对慢性鼻-鼻窦炎嗅觉的影响不同。
Laryngoscope. 2020 Oct;130(10):2311-2318. doi: 10.1002/lary.28332. Epub 2019 Oct 11.
3
Corticosteroid nasal irrigations are more effective than simple sprays in a randomized double-blinded placebo-controlled trial for chronic rhinosinusitis after sinus surgery.在鼻窦手术后慢性鼻-鼻窦炎的一项随机双盲安慰剂对照试验中,皮质类固醇鼻腔冲洗比单纯喷雾更有效。
Int Forum Allergy Rhinol. 2018 Apr;8(4):461-470. doi: 10.1002/alr.22093. Epub 2018 Feb 2.
4
Response to Glucocorticosteroids Predicts Olfactory Outcome After ESS in Chronic Rhinosinusitis.糖皮质激素治疗反应预测慢性鼻-鼻窦炎内镜鼻窦手术后嗅觉结局。
Laryngoscope. 2020 Jul;130(7):1616-1621. doi: 10.1002/lary.28233. Epub 2019 Aug 2.
5
Active olfactory training for the treatment of smelling disorders.主动嗅觉训练治疗嗅觉障碍
Ear Nose Throat J. 2012 May;91(5):198-203, 215. doi: 10.1177/014556131209100508.
6
[Analysis of factors affecting olfactory disfunctions in patients with chronic rhinosinusitis with nasal polyps].[慢性鼻-鼻窦炎伴鼻息肉患者嗅觉障碍影响因素分析]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 Apr 7;55(4):350-357. doi: 10.3760/cma.j.cn115330-20190614-00383.
7
Prevalence of sinusitis and efficacy of intranasal corticosteroid treatment on asthmatic symptoms in asthmatic patients with rhinosinusitis: a pilot study.鼻窦炎在合并鼻窦炎的哮喘患者中的患病率及鼻用糖皮质激素治疗对哮喘症状的疗效:一项初步研究。
Int Forum Allergy Rhinol. 2016 Apr;6(4):398-406. doi: 10.1002/alr.21672. Epub 2015 Dec 1.
8
[Olfactory function in patients undergoing FESS for chronic rhinosinusitis].[慢性鼻窦炎患者接受功能性鼻内镜鼻窦手术时的嗅觉功能]
Cas Lek Cesk. 2017 Summer;156(4):187-191.
9
[Analysis of olfactory rehabilitation after endoscopic sinus surgery in patients with chronic sinusitis and nasal polyps].[慢性鼻窦炎和鼻息肉患者内镜鼻窦手术后嗅觉康复的分析]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Jan;30(2):106-10.
10
Mucous Cytokine Levels in Chronic Rhinosinusitis-Associated Olfactory Loss.慢性鼻-鼻窦炎相关性嗅觉丧失中的黏液细胞因子水平
JAMA Otolaryngol Head Neck Surg. 2016 Aug 1;142(8):731-7. doi: 10.1001/jamaoto.2016.0927.

引用本文的文献

1
Systemic corticosteroids in treatment of chronic rhinosinusitis-A systematic review.全身用糖皮质激素治疗慢性鼻-鼻窦炎——一项系统评价
Eur Clin Respir J. 2023 Aug 4;10(1):2240511. doi: 10.1080/20018525.2023.2240511. eCollection 2023.
2
Applications of vibrational energy in the treatment of sinonasal disease: A scoping review.振动能量在治疗鼻-鼻窦疾病中的应用:范围综述。
Int Forum Allergy Rhinol. 2022 Nov;12(11):1397-1412. doi: 10.1002/alr.22988. Epub 2022 Mar 9.
3
Olfaction in chronic rhinosinusitis: comparing two different endonasal steroid application methods.慢性鼻-鼻窦炎中的嗅觉:比较两种不同的鼻内类固醇应用方法。
Eur Arch Otorhinolaryngol. 2017 Mar;274(3):1431-1435. doi: 10.1007/s00405-016-4341-6. Epub 2016 Oct 11.

本文引用的文献

1
Factors affecting the impact of olfactory loss on the quality of life and emotional coping ability.影响嗅觉丧失对生活质量和情绪应对能力影响的因素。
Rhinology. 2011 Aug;49(3):337-41. doi: 10.4193/Rhino10.130.
2
Mechanisms of the symptoms of rhinosinusitis.鼻窦炎症状的发生机制。
Rhinology. 2011 Jun;49(2):131-8.
3
Intranasal administration of drugs.
Arch Otolaryngol Head Neck Surg. 2008 Jun;134(6):643-6. doi: 10.1001/archotol.134.6.643.
4
European position paper on rhinosinusitis and nasal polyps 2007.《2007年欧洲鼻窦炎和鼻息肉立场文件》
Rhinol Suppl. 2007;20:1-136.
5
Normative data for the "Sniffin' Sticks" including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects.“嗅觉棒”的标准化数据,包括气味识别、气味辨别和嗅觉阈值测试:基于3000多名受试者的更新。
Eur Arch Otorhinolaryngol. 2007 Mar;264(3):237-43. doi: 10.1007/s00405-006-0173-0. Epub 2006 Sep 23.
6
Olfactory disorders and their consequences for quality of life.嗅觉障碍及其对生活质量的影响。
Acta Otolaryngol. 2005 Feb;125(2):116-21. doi: 10.1080/00016480410022787.
7
A study on the frequency of olfactory dysfunction.一项关于嗅觉功能障碍发生率的研究。
Laryngoscope. 2004 Oct;114(10):1764-9. doi: 10.1097/00005537-200410000-00017.
8
Prevalence of olfactory dysfunction: the skövde population-based study.嗅觉功能障碍的患病率:舍夫德基于人群的研究。
Laryngoscope. 2004 Apr;114(4):733-7. doi: 10.1097/00005537-200404000-00026.
9
Local and systemic administration of corticosteroids in the treatment of olfactory loss.局部和全身应用皮质类固醇治疗嗅觉丧失
Am J Rhinol. 2004 Jan-Feb;18(1):29-33.
10
[Olfactory dysfunctions. Epidemiology and therapy in Germany, Austria and Switzerland].[嗅觉功能障碍。德国、奥地利和瑞士的流行病学与治疗]
HNO. 2004 Feb;52(2):112-20. doi: 10.1007/s00106-003-0877-z.